Project Grant R44OD042685
Award Date 9/1/26
Completion Date 8/31/28
Dollars Obligated $1M
Funding Federal Agency
Awarding Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Birmingham, AL 35242, USA
Similar Awards
- The National Heart, Lung, and Blood Institute awarded MDC Studio, Inc. $309,813 on September 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop an automated vascular access device that enables less-experienced providers to safely and reliably perform central venous and arterial cannulation. The R61 phase focuses on automating the core steps of successful cannulation. MDC Studio will design, construct, and test sensors and automation to detect blood vessel...
- The National Institute for Minority Health and Health Disparities awarded Innovative Design Labs Inc. $3,093,181 on September 23, 2025, under the Minority Health and Health Disparities Research program (CFDA 93.307) to develop a modular simulator for venipuncture, peripheral intravenous catheter, and injection training that represents the diversity of patients encountered in U.S. healthcare settings. Current IV skill trainers simulate primarily healthy adult anatomy, creating gaps in...
- The Department of Health and Human Services National Institutes of Health Office of the Director awarded Tufts Medical Center Parent, Inc. (doing business as Tufts Medical Center) $498,040 on May 15, 2026, under the Research Infrastructure Programs (CFDA 93.351) to purchase a Fujifilm VisualSonics VEVO F2 ultrasound system for preclinical cardiovascular imaging research. The system will support 11 cardiovascular investigators at the Tufts Medical Center Molecular Cardiology Research Institute,...
- The National Cancer Institute awarded Rheotek Medical Inc. $1,045,569 under the Cancer Treatment Research program (CFDA 93.395) on September 1, 2026 for development of an ultra-precise needle delivery system for cutaneous cancer treatment. Rheotek Medical is developing the SoftTouch device, an automated intratumoral immunotherapy delivery system designed to address precision limitations in current manual injection methods for skin cancer. The device uses a miniaturized voice coil actuator to...
- The National Institute of Biomedical Imaging and Bioengineering awarded Brigham & Women's Hospital Inc. $1,583,125 on May 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop a multifunctional interventional device for biopsy and optical imaging-based phase-0 drug response measurements. The recipient will develop an interventional drug response assay (IDRA) device to enable biopsy-based phase-0 measurements...
- The National Institutes of Health Office of the Director awarded $350,000 to Seattle Children's Hospital (doing business as Seattle Children's Research Institute) on September 1, 2026, under the Research Infrastructure Programs (CFDA 93.351) to purchase a digital ventilated cage system from Tecniplast for the Behavioral Phenotyping Core vivarium. The DVC system incorporates continuous, real-time monitoring of animal activity and environmental cage parameters including temperature, humidity,...
- The National Institutes of Health National Heart Lung and Blood Institute awarded Nimble Surgical Incorporated $314,362 on September 15, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop FLEXLOCK, a manually operable anchoring guide catheter designed to simplify transradial complex percutaneous coronary interventions. FLEXLOCK delivers simultaneous active and passive support through an anchoring tip to provide stable coronary access during complex PCI...
- The National Institute of Biomedical Imaging and Bioengineering awarded Infinite Biomedical Technologies, LLC $362,530 on September 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to advance commercialization readiness for a 3D printed titanium, myoelectric-powered prosthetic digit system. Infinite Biomedical Technologies is developing the Point Powered, a durable myoelectric prosthesis designed for individuals with...
- The National Heart, Lung, and Blood Institute awarded Fastline LLC $306,383 on September 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop and test a second-generation one-handed central venous line (CVL) placement device. Fastline is engineering a simplified CVL insertion device that enables operators to perform all steps of central vein access—needle puncture, aspiration/injection, manometry testing, and guidewire placement—with a single hand while...
- The National Institutes of Health Office of the Director awarded $803,099 to Objective Biotechnology, Inc. on September 15, 2025, under the Research Infrastructure Programs (CFDA 93.351) to develop and advance the mini-mscope, a 3.8-gram miniaturized imaging device for mesoscale cortex-wide neural activity measurement in freely behaving mice. The Phase I Small Business Technology Transfer (STTR) project addresses limitations identified in beta testing by engineering a mini-mscope with a highly...